Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging

The objective of this study was to investigate in vitro the interactions between novel epidermal growth factor receptor kinase inhibitors (EGFRIs) developed for positron emission tomography (PET) imaging and the major efflux transporter breast cancer resistance protein (BCRP/ABCG2). Seven compounds...

Full description

Bibliographic Details
Main Authors:	Israa eAbdelrahman, Miriam eShmuel, Sara eEyal
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-11-01
Series:	Frontiers in Pharmacology
Subjects:	P-Glycoprotein imaging Breast cancer resistance protein epidermal growth factor receptor Positron emission tomography. epidermal growth factor receptor kinase inhibitors
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00257/full

Similar Items

Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
by: Leanne G. Ahronian, et al.
Published: (2017-04-01)

Progress and prospect of epidermal growth factor receptor tyrosine kinase inhibitor in treatment of non-small cell lung cancer
by: JIANG Hanshui, et al.
Published: (2022-12-01)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Shih-Chieh Chang, et al.
Published: (2011-06-01)

Serum Epidermal Growth Factor in Cancer Breast
by: El-Attar HA, et al.
Published: (2007-06-01)

Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
by: Laksmi Wulandari, et al.
Published: (2018-07-01)

Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
by: Sviatoslav Chekhun, et al.
Published: (2023-12-01)

The spatial organization of the epidermal growth factor receptor on the surface of colorectal carcinoma cells
by: Fournier, C
Published: (2015)

Epidermal growth factor receptor and anaplastic lymphoma kinase mutation in adenocarcinoma lung: Their incidence and correlation with histologic patterns
by: Pankaj Gupta, et al.
Published: (2019-01-01)

Epidermal growth factor receptor: Role in human cancer
by: Prashanth Rajaram, et al.
Published: (2017-01-01)

AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways
by: Wei Yin, et al.
Published: (2021-01-01)

Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
by: Jingwen Wei, et al.
Published: (2022-10-01)

Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
by: ANA D AVILA, et al.
Published: (2007-01-01)

Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population
by: Su Kang Kim, et al.
Published: (2016-12-01)

Prognostic role of epidermal growth factor receptors’ expression in patients with i-ii stage of non-small cell lung cancer
by: A.P. Kolesnik, et al.
Published: (2013-08-01)

Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
by: Katsuhiro Masago, et al.
Published: (2018-01-01)

Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities
by: Philomena Charlotte Dsouza, et al.
Published: (2017-01-01)

Esophageal Cancer and the Importance of Epidermal Growth Factor (EGFR)
by: Kazem Anvari, et al.
Published: (2014-04-01)

Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma
by: Ying-Yi Chen, et al.
Published: (2023-10-01)

Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
by: Chia-Yu Chu, et al.
Published: (2017-06-01)

Potential Role of EGF and EGFR in Tongue Coating Formation
by: Yi-Shuang Tang, et al.
Published: (2016-12-01)

Expression of Epidermal Growth Factor Receptor in Human Middle Ear Cholesteatoma
by: Ying-Che Hsu, et al.
Published: (2003-10-01)

Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer
by: Jonathan R. Thompson, et al.
Published: (2016-10-01)

Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
by: Sathishbabu Paranthaman, et al.
Published: (2020-12-01)

Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
by: Toshimitsu Yamaoka, et al.
Published: (2017-11-01)

A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor
by: Yongjian Huang, et al.
Published: (2021-11-01)

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2019-08-01)

A comparative study of cell block versus biopsy for detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement in adenocarcinoma lung
by: Vani Gupta, et al.
Published: (2019-01-01)

Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer
by: Seung Hun Jang, et al.
Published: (2022-07-01)

Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
by: Eero Vasar, et al.
Published: (2016-07-01)

Expression of epidermal growth factor receptor in advance stage nonkeratinizing nasopharyngeal carcinoma in West Sumatra, Indonesia
by: Rahman Sukri, et al.
Published: (2018-01-01)

Correlation between Grade in Transitional Cell Carcinoma (TCC) and Expression of Epidermal Growth Factor Receptor (EGFR)
by: MR Jallali Nadoushan, et al.
Published: (2007-08-01)

Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
by: Zhang H
Published: (2016-11-01)

Effect of epidermal growth factor on proliferation and migration of retinal pigment epithelial cells through EGFR/AKT signaling pathway
by: Xiao-Dong Chen, et al.
Published: (2018-02-01)

Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer
by: Nagraj Gururaj Huilgol, et al.
Published: (2017-01-01)

BRET biosensor analysis of receptor tyrosine kinase functionality
by: Sana eSiddiqui, et al.
Published: (2013-04-01)

Research Progress on Resistance Mechanisms of Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
by: Yuan LI, et al.
Published: (2012-02-01)

Mechanisms of Resistance to the Third-generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
by: Lianfang NI, et al.
Published: (2018-02-01)

Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
by: Svetlana V. Odintsova, et al.
Published: (2020-07-01)

Epidermal Growth Factor Receptor Silencing Blunts the Slow Force Response to Myocardial Stretch
by: María S. Brea, et al.
Published: (2016-10-01)

Prognostic role of epidermal growth factor receptor in localized breast cancer: 15 Years of follow-up
by: Nešković-Konstantinović Zora, et al.
Published: (2006-01-01)